A comparison of 99mTc-DTPA clearance and translocation of nano particles in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020
Pulmonary epithelial permeability with 99mTc-DTPA aerosol in patients with spontaneous pneumothorax Source: Eur Respir J 2003; 22: Suppl. 45, 592s Year: 2003
Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations Source: Eur Respir J 2015; 46: 1055-1064 Year: 2015
Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019
Assessment of lung epithelial permeability by 99m Tc-DTPA and its relation to pulmonary functions in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 495s Year: 2001
Assessment of alveolar clearance with technetium-99m-DTPA radio-aerosol in patients who are active, passive and former smokers; preliminary study Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018
The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015
Long-term course of lung clearance index among patients with cystic fibrosis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020
Mucocilary clearance of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Mucociliary clearance in patients with chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 302s Year: 2005
Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020
Relationship between HRCT findings and clearance of technetium -99m-DTPA in the evaluation of patients with Idiopathic Pulmonary Fibrosis (IPF). Source: Eur Respir J 2002; 20: Suppl. 38, 457s Year: 2002
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021 Year: 2021